Phil Norris

Over the last 3-years Phil has been working at AspenTech as lead consultant for the pharmaceutical industries in Europe. In this role he has engaged with companies including AstraZeneca, Schering AG, GSK and Novartis and has published a number of articles on cost reduction, operational excellence, speeding new products to market, economic value realization and product life cycle management.

Phil is a member of the Royal Society of Chemistry, and is a Chartered Chemist. He holds a 1st Class honours degree in Biochemistry from the University of London .